List of Tables
    Table 1. Systemic Sclerosis Drug CAGR in Value, United States VS Global, 2017 VS 2022 VS 2028
    Table 2. Systemic Sclerosis Drug Market Trends
    Table 3. Systemic Sclerosis Drug Market Drivers
    Table 4. Systemic Sclerosis Drug Market Challenges
    Table 5. Systemic Sclerosis Drug Market Restraints
    Table 6. Global Systemic Sclerosis Drug Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 7. United States Systemic Sclerosis Drug Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 8. Global Systemic Sclerosis Drug Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 9. United States Systemic Sclerosis Drug Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 10. Top Systemic Sclerosis Drug Manufacturers in Global Market, Ranking by Revenue (2021)
    Table 11. Global Systemic Sclerosis Drug Revenue by Manufacturer, (US$ Million), 2017-2022
    Table 12. Global Systemic Sclerosis Drug Revenue Share by Manufacturer, 2017-2022
    Table 13. Global Systemic Sclerosis Drug Sales by Manufacturer, (K Pcs), 2017-2022
    Table 14. Global Systemic Sclerosis Drug Sales Share by Manufacturer, 2017-2022
    Table 15. Global Systemic Sclerosis Drug Price by Manufacturer (2017-2022) & (USD/Pcs)
    Table 16. Global Systemic Sclerosis Drug Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 17. Global Systemic Sclerosis Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Systemic Sclerosis Drug as of 2021)
    Table 18. Top Players of Systemic Sclerosis Drug in Global Market, Headquarters and Distribution of Producing Region
    Table 19. Manufacturers Systemic Sclerosis Drug Product Type
    Table 20. Date of International Manufacturers Enter into Systemic Sclerosis Drug Market
    Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 22. Top Systemic Sclerosis Drug Players in United States Market, Ranking by Revenue (2021)
    Table 23. United States Systemic Sclerosis Drug Revenue by Players, (US$ Million), 2020, 2021 & 2022
    Table 24. United States Systemic Sclerosis Drug Revenue Share by Players, 2020, 2021 & 2022
    Table 25. United States Systemic Sclerosis Drug Sales by Players, (K Pcs), 2020, 2021 & 2022
    Table 26. United States Systemic Sclerosis Drug Sales Share by Players, 2020, 2021 & 2022
    Table 27. Global Systemic Sclerosis Drug Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
    Table 28. Global Systemic Sclerosis Drug Sales in Volume by Region (2017-2022) & (K Pcs)
    Table 29. Global Systemic Sclerosis Drug Sales in Volume Forecast by Region (2023-2028) & (K Pcs)
    Table 30. Global Systemic Sclerosis Drug Sales in Value by Region (2017-2022) & (US$ Million)
    Table 31. Global Systemic Sclerosis Drug Sales in Value Forecast by Region (2023-2028) & (US$ Million)
    Table 32. North America Systemic Sclerosis Drug Sales in Volume by Country (2017-2028) & (K Pcs)
    Table 33. North America Systemic Sclerosis Drug Sales in Value by Country (2017-2028) & (US$ Million)
    Table 34. Asia Pacific Systemic Sclerosis Drug Sales in Volume by Region (2017-2028) & (K Pcs)
    Table 35. Asia Pacific Systemic Sclerosis Drug Sales in Value by Region (2017-2028) & (US$ Million)
    Table 36. Europe Systemic Sclerosis Drug Sales in Volume by Country (2017-2028) & (K Pcs)
    Table 37. Europe Systemic Sclerosis Drug Sales in Value by Country (2017-2028) & (US$ Million)
    Table 38. Latin America Systemic Sclerosis Drug Sales in Volume by Country (2017-2028) & (K Pcs)
    Table 39. Latin Americaa Systemic Sclerosis Drug Sales in Value by Country (2017-2028) & (US$ Million)
    Table 40. Middle East and Africa Systemic Sclerosis Drug Sales in Volume by Country (2017-2028) & (K Pcs)
    Table 41. Middle East and Africa Systemic Sclerosis Drug Sales in Value by Country (2017-2028) & (US$ Million)
    Table 42. Allergan Plc Corporation Information
    Table 43. Allergan Plc Description and Business Overview
    Table 44. Allergan Plc Systemic Sclerosis Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 45. Allergan Plc Systemic Sclerosis Drug Product
    Table 46. Allergan Plc Recent Development
    Table 47. Angion Biomedica Corp. Corporation Information
    Table 48. Angion Biomedica Corp. Description and Business Overview
    Table 49. Angion Biomedica Corp. Systemic Sclerosis Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 50. Angion Biomedica Corp. Product
    Table 51. Angion Biomedica Corp. Recent Development
    Table 52. arGentis Pharmaceuticals, LLC Corporation Information
    Table 53. arGentis Pharmaceuticals, LLC Description and Business Overview
    Table 54. arGentis Pharmaceuticals, LLC Systemic Sclerosis Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 55. arGentis Pharmaceuticals, LLC Product
    Table 56. arGentis Pharmaceuticals, LLC Recent Development
    Table 57. Bayer AG Corporation Information
    Table 58. Bayer AG Description and Business Overview
    Table 59. Bayer AG Systemic Sclerosis Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 60. Bayer AG Product
    Table 61. Bayer AG Recent Development
    Table 62. BioLineRx, Ltd. Corporation Information
    Table 63. BioLineRx, Ltd. Description and Business Overview
    Table 64. BioLineRx, Ltd. Systemic Sclerosis Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 65. BioLineRx, Ltd. Product
    Table 66. BioLineRx, Ltd. Recent Development
    Table 67. BiOrion Technologies B.V. Corporation Information
    Table 68. BiOrion Technologies B.V. Description and Business Overview
    Table 69. BiOrion Technologies B.V. Systemic Sclerosis Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 70. BiOrion Technologies B.V. Product
    Table 71. BiOrion Technologies B.V. Recent Development
    Table 72. Boehringer Ingelheim GmbH Corporation Information
    Table 73. Boehringer Ingelheim GmbH Description and Business Overview
    Table 74. Boehringer Ingelheim GmbH Systemic Sclerosis Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 75. Boehringer Ingelheim GmbH Product
    Table 76. Boehringer Ingelheim GmbH Recent Development
    Table 77. Bristol-Myers Squibb Company Corporation Information
    Table 78. Bristol-Myers Squibb Company Description and Business Overview
    Table 79. Bristol-Myers Squibb Company Systemic Sclerosis Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 80. Bristol-Myers Squibb Company Product
    Table 81. Bristol-Myers Squibb Company Recent Development
    Table 82. Corbus pharmaceuticals, Inc. Corporation Information
    Table 83. Corbus pharmaceuticals, Inc. Description and Business Overview
    Table 84. Corbus pharmaceuticals, Inc. Systemic Sclerosis Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 85. Corbus pharmaceuticals, Inc. Product
    Table 86. Corbus pharmaceuticals, Inc. Recent Development
    Table 87. CSL Limited Corporation Information
    Table 88. CSL Limited Description and Business Overview
    Table 89. CSL Limited Systemic Sclerosis Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 90. CSL Limited Product
    Table 91. CSL Limited Recent Development
    Table 92. Daval International Limited Corporation Information
    Table 93. Daval International Limited Description and Business Overview
    Table 94. Daval International Limited Systemic Sclerosis Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 95. Daval International Limited Product
    Table 96. Daval International Limited Recent Development
    Table 97. Digna Biotech, S.L. Corporation Information
    Table 98. Digna Biotech, S.L. Description and Business Overview
    Table 99. Digna Biotech, S.L. Systemic Sclerosis Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 100. Digna Biotech, S.L. Product
    Table 101. Digna Biotech, S.L. Recent Development
    Table 102. F. Hoffmann-La Roche Ltd. Corporation Information
    Table 103. F. Hoffmann-La Roche Ltd. Description and Business Overview
    Table 104. F. Hoffmann-La Roche Ltd. Systemic Sclerosis Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 105. F. Hoffmann-La Roche Ltd. Product
    Table 106. F. Hoffmann-La Roche Ltd. Recent Development
    Table 107. Fibrocell Science, Inc. Corporation Information
    Table 108. Fibrocell Science, Inc. Description and Business Overview
    Table 109. Fibrocell Science, Inc. Systemic Sclerosis Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 110. Fibrocell Science, Inc. Product
    Table 111. Fibrocell Science, Inc. Recent Development
    Table 112. GenKyoTex S.A. Corporation Information
    Table 113. GenKyoTex S.A. Description and Business Overview
    Table 114. GenKyoTex S.A. Systemic Sclerosis Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 115. GenKyoTex S.A. Product
    Table 116. GenKyoTex S.A. Recent Development
    Table 117. GlaxoSmithKline Plc Corporation Information
    Table 118. GlaxoSmithKline Plc Description and Business Overview
    Table 119. GlaxoSmithKline Plc Systemic Sclerosis Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 120. GlaxoSmithKline Plc Product
    Table 121. GlaxoSmithKline Plc Recent Development
    Table 122. Key Raw Materials Lists
    Table 123. Raw Materials Key Suppliers Lists
    Table 124. Systemic Sclerosis Drug Customers List
    Table 125. Systemic Sclerosis Drug Distributors List
    Table 126. Research Programs/Design for This Report
    Table 127. Key Data Information from Secondary Sources
    Table 128. Key Data Information from Primary Sources
List of Figures
    Figure 1. Systemic Sclerosis Drug Product Picture
    Figure 2. Global Systemic Sclerosis Drug Revenue, (US$ Million), 2017 VS 2022 VS 2028
    Figure 3. Global Systemic Sclerosis Drug Market Size 2017-2028 (US$ Million)
    Figure 4. Global Systemic Sclerosis Drug Sales 2017-2028 (K Pcs)
    Figure 5. United States Systemic Sclerosis Drug Revenue, (US$ Million), 2017 VS 2022 VS 2028
    Figure 6. United States Systemic Sclerosis Drug Market Size 2017-2028 (US$ Million)
    Figure 7. United States Systemic Sclerosis Drug Sales 2017-2028 (K Pcs)
    Figure 8. United States Systemic Sclerosis Drug Market Share in Global, in Value (US$ Million) 2017-2028
    Figure 9. United States Systemic Sclerosis Drug Market Share in Global, in Volume (K Pcs) 2017-2028
    Figure 10. Systemic Sclerosis Drug Report Years Considered
    Figure 11. Product Picture of ARG-201
    Figure 12. Product Picture of Belimumab
    Figure 13. Product Picture of BL-1110
    Figure 14. Product Picture of BOT-191
    Figure 15. Product Picture of C-82
    Figure 16. Product Picture of Others
    Figure 17. Global Systemic Sclerosis Drug Market Share by Type in 2022 & 2028
    Figure 18. Global Systemic Sclerosis Drug Sales in Value by Type (2017-2028) & (US$ Million)
    Figure 19. Global Systemic Sclerosis Drug Sales Market Share in Value by Type (2017-2028)
    Figure 20. Global Systemic Sclerosis Drug Sales by Type (2017-2028) & (K Pcs)
    Figure 21. Global Systemic Sclerosis Drug Sales Market Share in Volume by Type (2017-2028)
    Figure 22. Global Systemic Sclerosis Drug Price by Type (2017-2028) & (USD/Pcs)
    Figure 23. United States Systemic Sclerosis Drug Market Share by Type in 2022 & 2028
    Figure 24. United States Systemic Sclerosis Drug Sales in Value by Type (2017-2028) & (US$ Million)
    Figure 25. United States Systemic Sclerosis Drug Sales Market Share in Value by Type (2017-2028)
    Figure 26. United States Systemic Sclerosis Drug Sales by Type (2017-2028) & (K Pcs)
    Figure 27. United States Systemic Sclerosis Drug Sales Market Share in Volume by Type (2017-2028)
    Figure 28. United States Systemic Sclerosis Drug Price by Type (2017-2028) & (USD/Pcs)
    Figure 29. Product Picture of Hospital
    Figure 30. Product Picture of Clinic
    Figure 31. Product Picture of ASCs
    Figure 32. Product Picture of Others
    Figure 33. Global Systemic Sclerosis Drug Market Share by Application in 2022 & 2028
    Figure 34. Global Systemic Sclerosis Drug Sales in Value by Application (2017-2028) & (US$ Million)
    Figure 35. Global Systemic Sclerosis Drug Sales Market Share in Value by Application (2017-2028)
    Figure 36. Global Systemic Sclerosis Drug Sales by Application (2017-2028) & (K Pcs)
    Figure 37. Global Systemic Sclerosis Drug Sales Market Share in Volume by Application (2017-2028)
    Figure 38. Global Systemic Sclerosis Drug Price by Application (2017-2028) & (USD/Pcs)
    Figure 39. United States Systemic Sclerosis Drug Market Share by Application in 2022 & 2028
    Figure 40. United States Systemic Sclerosis Drug Sales in Value by Application (2017-2028) & (US$ Million)
    Figure 41. United States Systemic Sclerosis Drug Sales Market Share in Value by Application (2017-2028)
    Figure 42. United States Systemic Sclerosis Drug Sales by Application (2017-2028) & (K Pcs)
    Figure 43. United States Systemic Sclerosis Drug Sales Market Share in Volume by Application (2017-2028)
    Figure 44. United States Systemic Sclerosis Drug Price by Application (2017-2028) & (USD/Pcs)
    Figure 45. North America Systemic Sclerosis Drug Sales in Volume Growth Rate 2017-2028 (K Pcs)
    Figure 46. North America Systemic Sclerosis Drug Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 47. U.S. Systemic Sclerosis Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 48. Canada Systemic Sclerosis Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 49. Europe Systemic Sclerosis Drug Sales in Volume Growth Rate 2017-2028 (K Pcs)
    Figure 50. Europe Systemic Sclerosis Drug Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 51. Germany Systemic Sclerosis Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 52. France Systemic Sclerosis Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 53. U.K. Systemic Sclerosis Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 54. Italy Systemic Sclerosis Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 55. Russia Systemic Sclerosis Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 56. Asia-Pacific Systemic Sclerosis Drug Sales in Volume Growth Rate 2017-2028 (K Pcs)
    Figure 57. Asia-Pacific Systemic Sclerosis Drug Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 58. China Systemic Sclerosis Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 59. Japan Systemic Sclerosis Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 60. South Korea Systemic Sclerosis Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 61. India Systemic Sclerosis Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 62. Australia Systemic Sclerosis Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 63. Taiwan Systemic Sclerosis Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 64. Indonesia Systemic Sclerosis Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 65. Thailand Systemic Sclerosis Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 66. Malaysia Systemic Sclerosis Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 67. Philippines Systemic Sclerosis Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 68. Latin America Systemic Sclerosis Drug Sales in Volume Growth Rate 2017-2028 (K Pcs)
    Figure 69. Latin America Systemic Sclerosis Drug Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 70. Mexico Systemic Sclerosis Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 71. Brazil Systemic Sclerosis Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 72. Argentina Systemic Sclerosis Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 73. Middle East & Africa Systemic Sclerosis Drug Sales in Volume Growth Rate 2017-2028 (K Pcs)
    Figure 74. Middle East & Africa Systemic Sclerosis Drug Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 75. Turkey Systemic Sclerosis Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 76. Saudi Arabia Systemic Sclerosis Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 77. U.A.E Systemic Sclerosis Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 78. Systemic Sclerosis Drug Value Chain
    Figure 79. Systemic Sclerosis Drug Production Process
    Figure 80. Channels of Distribution
    Figure 81. Distributors Profiles
    Figure 82. Bottom-up and Top-down Approaches for This Report
    Figure 83. Data Triangulation
    Figure 84. Key Executives Interviewed